Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-Carboxylcytosine levels are elevated in human breast cancers and gliomas.
Eleftheriou M, Pascual AJ, Wheldon LM, Perry C, Abakir A, Arora A, Johnson AD, Auer DT, Ellis IO, Madhusudan S, Ruzov A. Eleftheriou M, et al. Among authors: madhusudan s. Clin Epigenetics. 2015 Aug 21;7(1):88. doi: 10.1186/s13148-015-0117-x. eCollection 2015. Clin Epigenetics. 2015. PMID: 26300993 Free PMC article.
Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?
Abdel-Fatah T, Arora A, Gorguc I, Abbotts R, Beebeejaun S, Storr S, Mohan V, Hawkes C, Soomro I, Lobo DN, Parsons SL, Madhusudan S. Abdel-Fatah T, et al. Among authors: madhusudan s. Antioxid Redox Signal. 2013 Jun 20;18(18):2392-8. doi: 10.1089/ars.2012.4873. Epub 2012 Oct 19. Antioxid Redox Signal. 2013. PMID: 22894650 Free article.
Targeting XRCC1 deficiency in breast cancer for personalized therapy.
Sultana R, Abdel-Fatah T, Abbotts R, Hawkes C, Albarakati N, Seedhouse C, Ball G, Chan S, Rakha EA, Ellis IO, Madhusudan S. Sultana R, et al. Among authors: madhusudan s. Cancer Res. 2013 Mar 1;73(5):1621-34. doi: 10.1158/0008-5472.CAN-12-2929. Epub 2012 Dec 19. Cancer Res. 2013. PMID: 23253910
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings.
Abdel-Fatah TM, Perry C, Dickinson P, Ball G, Moseley P, Madhusudan S, Ellis IO, Chan SY. Abdel-Fatah TM, et al. Among authors: madhusudan s. Ann Oncol. 2013 Nov;24(11):2801-7. doi: 10.1093/annonc/mdt277. Epub 2013 Aug 1. Ann Oncol. 2013. PMID: 23908177 Free article.
189 results